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Abstract An Escherichia coli strain was constructed in which
both chromosomal genes encoding elongation factor (EF)-Tu
(tufA and tufB) have been inactivated with precise coding se-
quence replacements. A tufA gene in an expression vector is
supplied as the sole EF-Tu source. By using plasmid replace-
ment, based on plasmid incompatibility, mutant EF-Tu variants
with a large CP-terminal extension up to 270 amino acids were
studied and proved to be functional in a strain lacking the chro-
mosomal tufA and tufB genes.
' 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Elongation factor (EF)-Tu plays a central role in the pro-
karyotic translational apparatus by supplying the ribosomal A
site with charged tRNA during peptide chain elongation [1].
The gene encoding this translation factor is present in multiple
copies in the genome of many organisms [2]. Two EF-Tu
genes (tuf) are encoded in the genomes of Escherichia coli
[3] and Salmonella typhimurium [4], probably re£ecting a
gene duplication event [1]. The multiple copies of the gene
and the fact that both genes are members of operons with
other indispensable genes make it di⁄cult to use the arsenal
of bacterial genetics to study mutant variants of this impor-
tant translation factor.
Several approaches have been taken to inactivate either one
of the encoding genes in E. coli, tufA or tufB. Insertional
inactivation of tufB could be achieved easily [5]. However,
tufA could not be inactivated by a similar approach [6]. The
two proteins di¡er only in the last encoded amino acid residue
^ glycine in tufA and serine in tufB. The operon organization
shows even more di¡erences: tufA is encoded as the last gene
in the rpsL operon containing the genes rpsL-rpsG-fusA-tufA
at the 74.7 min map position [7], whereas tufB is encoded in
an operon with the thrU-tyrU-glyT-thrT-tufB genes at the 89
min map position [8], also in this case being the last gene in
the operon. Functional di¡erences between the two EF-Tu
species have not been observed [6,9]. Explanations for the
unsuccessful attempts to inactivate the tufA gene have been
attributed to the importance of the other genes encoded in the
same operon, or to the possible secondary e¡ect of the se-
quence alterations or transposon insertions. Alternatively,
the higher expression level of the tufA gene might not be
compensated by a single tufB copy. Nevertheless, Kraal and
coworkers later showed that, using precise coding sequence
replacement, either one of the tuf genes could be deleted,
making it possible to characterize the physiological e¡ects
caused by inactivation of either one of the two tuf genes
[10]. Successful inactivation of both chromosomal tuf genes
in the same strain has not yet been reported.
In the present work, we have inactivated both chromosomal
tuf genes by replacing tufB with a kanamycin phosphotrans-
ferase cassette (vtufB : :kan), and tufA with a chloramphenicol
acetyltransferase cassette (vtufA: :cat). The sole EF-Tu source
is a plasmid-encoded tufA gene in an expression vector, under
control of the Ptrc promoter and a LacI-Olac system. Due to
the high level of EF-Tu needed, expression induction by IPTG
is necessary for growth, making the double deletion strain
IPTG dependent. In order to construct strains with di¡erent
mutant EF-Tu variants and make it possible to study these
proteins and their functional in£uences in the absence of any
chromosomal EF-Tu contribution, a plasmid replacement sys-
tem was used. By using this plasmid replacement procedure,
plasmids encoding mutant EF-Tu variants with CP-terminally
tagged proteins were introduced as the sole source of EF-Tu.
As judged by physiological properties such as growth rate,
IPTG dependence, and kirromycin sensitivity, the CP-termi-
nally tagged EF-Tu with an extension up to 323 amino acids
is functional.
2. Materials and methods
2.1. E. coli strains and media
The K12 E. coli strains used in this study are MG1655 (tufAþ,
tufBþ), UI232 (tufA(Kir-R), tufB(Bo)) [11], and DH5K. The media
were made as described by Miller [12]. The strains were grown in
LB broth, if nothing else is stated. To select for antibiotic resistance,
100 Wg/ml ampicillin, 25 Wg/ml tetracycline, 30 Wg/ml kanamycin or 50
Wg/ml kirromycin was used. IPTG was used in the 0.1^1.0 mM con-
centration range to induce expression of the cloned genes.
2.2. PCR ampli¢cations
The gene encoding EF-Tu (tufA) was obtained by using the PCR
procedure and a chromosomal template from the strain MG1655. The
reaction mixtures were made for Vent polymerase (NEB) following
the manufacturer’s protocol, with minor modi¢cations as indicated in
the text. To amplify the tufA gene including its stop codon, the oli-
gonucleotide SR-7 (5P-GCTGAATTCGTGTCTAAAGAAAAATTT-
GAACG-3P ; sequence homology with the template is underlined) was
used as upstream primer and SR-8 (5P-GTCGGATCCGCCCTTTT-
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CAATTCAAAAC-3P ; sequence homology with the template is under-
lined) as downstream primer. For CP fusion of the tufA gene, SR-7
was used as upstream primer and SR-9 (5P-ATAGGATCCGCCC-
GAAACTTTAGCAACAAC-3P) as downstream primer. The reaction
mixture with 2 mM MgCl2 was pre-heated to 95‡C for 2.5 min; there-
after, 30 cycles were run with denaturation for 60 s at 94‡C, annealing
for 60 s at 55‡C and extension for 2 min at 72‡C. After the cycles were
completed, further incubation at 72‡C for 5 min was used as terminal
extension step.
2.3. Plasmid constructions
All plasmids described in this study are illustrated schematically in
Fig. 1. DNA work was performed as described by Sambrook et al.
[13]. Restriction enzymes were obtained from New England Biolabs,
Gibco Life Sciences, and MBI Fermentas. DNA fragments were iso-
lated using Qiaex II Gel Extraction Kit (Qiagen). Plasmid prepara-
tions were done using Qiagen and Jetprep plasmid preparation kits.
PCR-ampli¢ed tufA sequences with or without the original stop
codon were cloned into pTRC99A (Pharmacia Biotech), using £ank-
ing upstream EcoRI and downstream BamHI restriction sites, result-
ing in the plasmids pTRCtufA and pTRCtufACEX, respectively. The
tetracycline-resistant variant of pTRCtufACEX is pTRCtufACEX-
Tc, which confers tetracycline but not ampicillin resistance. To con-
struct the latter plasmid, the unique FspI site within the bla gene was
used to insert an EcoRI^StyI fragment of pBR322 encoding the tet
gene with blunt ends ¢lled in with Vent-polymerase.
In order to construct CP-terminal fusions to EF-Tu, a ¢lled-in
downstream BamHI site in pTRCtufACEX was used to join the
tufA coding sequence to a blunt upstream end of Z domain multi-
mer-coding fragments generated by FspI cleavage. This gave an in-
frame coding sequence fusion and a protein linker sequence of
7 amino acid residues (GSQHDEA) between the two fused proteins.
HindIII sites at the downstream end of the Z multimer fragments
were used to construct tufA-Z2, tufA-Z3, tufA-Z4, and tufA-Z5 gene
fusions in plasmids pTRCtufAZ2, pTRCtufAZ3, pTRCtufAZ4 and
pTRCtufAZ5, respectively.
2.4. Preparation of fusion proteins
Puri¢cation of proteins on IgG-Sepharose (Amersham-Pharmacia
Biotech) was performed as described by Nilsson et al. [14]. All sam-
ples were lyophilized.
2.5. Protein gel electrophoresis
SDS^polyacrylamide gel electrophoresis (PAGE) was used for pro-
tein separation. The gels (0.75 mm thick) were run in a Pharmacia
Midget gel apparatus with 5% (w/v) polyacrylamide as stacking and
15% (w/v) as resolution gels. Protein bands were visualized by Coo-
massie brilliant blue G staining [15].
2.6. Doubling time determinations
Log phase cultures with bacteria were grown in LB medium sup-
plemented with ampicillin (100 Wg/ml) and IPTG (1 mM); growth was
followed at 37‡C by measuring the OD540.
2.7. Gene deletions
Strains constructed in this study are shown in Table 1. Chromo-
somal inactivation of the tufB gene in E. coli MG1655 was completed
by homologous recombination using the pKNG101-mediated gene
deletion system [16]. The coding sequence of tufB, including the start
codon ATG and the stop signal TAA, was replaced with the kana-
mycin phosphotransferase gene of the plasmid pUC4K (Pharmacia)
with £anking EcoRI sites, resulting in the strain SR92 (vtufB : :kan).
Strain AZ32 (vtufA: :cat) was obtained from B. Kraal [10]. Using
SR92 as a host, with either plasmids pTRCtufA or pTRCtufACEX,
it was possible to remove the tufAþ gene by P1 phage transduction
[17] using a lysate originating from AZ32 (tufA: :cat) [10]. As a result,
strains were obtained having both chromosomal tuf genes deleted
(tufA : :cat (74.7 min); tufB : :kan (89.9 min)) and harboring the plas-
mids encoding di¡erent variants of EF-Tu.
2.8. Plasmid replacement
Starting with strain SR143 [tufA : :cat ; tufB : :kan] the plasmid
pTRCtufACEX expressing EF-Tu could be replaced by plasmids en-
coding modi¢ed EF-Tu genes. Competent cells were prepared and
transformations were carried out as described by Inoune et al. [18],
but 3^4 h long phenotypic expression was necessary for successful
transformation, before spreading the cells on the selective plates.
SR143, harboring the plasmid pTRCtufACEX, was transformed
with the plasmid pTRCtufACEX-Tc and plated on tetracycline/
IPTG plates to select for the latter plasmid. The transformants were
screened for ampicillin sensitivity to indicate the loss of pTRCtufA-
CEX. Next, SR143 cells harboring the plasmid pTRCtufACEX-Tc
were transformed with plasmids pTRCtufAZ2, pTRCtufAZ3,
pTRCtufAZ4 or pTRCtufAZ5 conferring resistance to ampicillin.
Transformants were selected on ampicillin/IPTG plates and screened
for tetracycline sensitivity to indicate the loss of pTRCtufACEX-Tc.
3. Results
An E. coli strain was constructed in which both chromo-
somal genes encoding EF-Tu have been precisely replaced by
antibiotic resistance cassettes (vtufB : :kan ;vtufA: :cat). The
sole EF-Tu source in the cell is provided by a plasmid-en-
coded tufA gene. The plasmid expressing EF-Tu was con-
structed to give resistance to either ampicillin or tetracycline.
Such plasmids can be replaced with each other as a result of
plasmid incompatibility, as demonstrated for plasmids with
the same replication origin and di¡erent resistance markers.
Using this plasmid-replacement procedure, plasmids encoding
mutant EF-Tu variants with CP-terminally tagged proteins can
be introduced as the sole sources of EF-Tu.
3.1. Construction and functional test of CP-terminally tagged
EF-Tu variants
The coding sequence of tufAþ with its original stop codon
was cloned by PCR and ligated into pTRC99A (Pharmacia-
Biotech), resulting in the plasmid pTRCtufA. In this expres-
Plasmid Expression casette Resistance
pTRCtufA
pTRCtufAZn
pTRCtufACEX
EcoRl
EcoRl
EcoRl
BamHI
BamHI
Hindlll
Hindlll
Hindlll
Term
Term
Term
Ptrc
Ptrc
Ptrc
Ampicillin
Ampicillin
Ampicillin
(Tetracyclin in
pTRCtufACEX-Tc)
tufA
tufA
tufA
Zn-tag
GSSRVDLQACKLGCFGG
   MSKEK........VVAKVLG*
MEFVSKEK........VVAKVLG*
MEFVSKEK........VVAKVLGGSSRVDLQACKLGCFGG*
EF-Tu
pTRCtufA
pTRCtufACEX
A
B
Fig. 1. A: Sequence alterations in studied EF-Tu protein variants.
The addition of three NP-terminal amino acids (MEF) and the re-
placement of the NP-terminal methionine (GUG) with valine are
due to sequence speci¢cities in the expression vector in plasmids
pTRCtufA and pTRCtufACEX, and the CP-tagged variants. The
amino acid sequence of the short CP-terminal extension tag is also
shown for pTRCtufACEX. B: Expression cassettes in the plasmids
showing the used restriction enzyme sites, the Trc promoter (Ptrc),
and the rrnBT1T2 terminator (Term). The Zn tag stands for the
CP-terminal extensions consisting of 2, 3, 4 or 5 IgG binding Z do-
mains in plasmids pTRCtufAZ2, pTRCtufAZ3, pTRCtufAZ4 or
pTRCtufAZ5, respectively.
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sion plasmid, the tufA gene is under control of the Ptrc pro-
moter and a LacI-Olac system (Fig. 1).
To construct tufA with CP-terminal fusions, the tufA coding
sequence without the original stop codon was cloned by PCR
and ligated into pTRC99A expression vector, resulting in the
plasmid pTRCtufACEX. The expression is under the control
of the Ptrc promoter and the LacI-Olac system, and the ex-
pressed protein has a 17 amino acid long CP-terminal sequence
tag (GSSRVDLQACKLGCFGG) (Fig. 1A). The gene also
carries a set of unique restriction enzyme recognition sites in
the coding sequence of this short tag, making it possible to
insert heterologous sequences in-frame with the tufA coding
sequence, thus giving di¡erent CP-terminal protein fusions. A
tetracycline-resistant variant (pTRCtufACEX-Tc) of pTRCtu-
fACEX was also constructed that confers tetracycline but not
ampicillin resistance after this modi¢cation.
In order to construct 3P-terminal fusions to tufA, IgG bind-
ing Z domain multimer-coding fragments (Z2, Z3, Z4, and Z5)
were cloned into pTRCtufACEX, resulting in tufA-Z2, tufA-
Z3, tufA-Z4, and tufA-Z5 gene fusions in plasmids pTRCtu-
fAZ2, pTRCtufAZ3, pTRCtufAZ4 and pTRCtufAZ5, respec-
tively. The sequence between the fused genes codes for a pro-
tein linker of seven amino acid residues (GSQHDEA).
In the E. coli strain UI232, tufA is mutated to give a kirro-
mycin-resistant EF-Tu (Ar) while tufB is mutated to give a
non-functional protein product (Bo) [11], making the strain
kirromycin-resistant. This phenotype has previously been
shown to be overruled by introducing a plasmid-borne wild-
type tufAþ gene that expresses a kirromycin-sensitive EF-Tu
[19,20]. To determine if the kirromycin-resistant phenotype of
strain UI232 is complemented by the fusion protein con-
structs, this strain was transformed with plasmids pTRC99A,
pTRCtufA and pTRCtufACEX, and by the constructs
pTRCtufAZ2, pTRCtufAZ3, pTRCtufAZ4 and pTRCtufAZ5
which express the fusion proteins. The transformants were
tested for growth on Ap, Ap/IPTG, Ap/Kir, and Ap/IPTG/
Kir plates. As shown in Table 2, the control strain UI232 with
plasmid pTRC99A grows as expected on all four test plates.
UI232 transformed with pTRCtufA or pTRCtufACEX grows
on Ap, Ap/IPTG, and Ap/Kir plates, but not on Ap/IPTG/
Kir plates. The test of plasmid pTRCtufACEX-Tc and the
plasmids encoding the CP-terminally tagged fusion proteins
gave similar results. These ¢ndings suggest that the plasmid-
borne EF-Tu proteins are functional, since they change the
phenotype from kirromycin resistance to sensitivity upon ex-
pression.
3.2. Gene deletions
Using chromosomal gene replacement [16], the coding se-
quence of the chromosomal tufB gene was replaced with a
kanamycin resistance cassette from pUC4K (Pharmacia), re-
sulting in the strain SR92. With SR92 as a host, in the pres-
ence of either pTRCtufA or pTRCtufACEX, it was possible
to remove the chromosomal tufAþ gene using P1 phage trans-
duction with a lysate originating from strain AZ32 (tufA: :cat)
[10]. These steps gave the strain SR143 that has both chro-
mosomal tuf genes deleted [tufA : :cat (74.7 min); tufB : :kan
(89.9 min)] (Fig. 2). Due to the high level of EF-Tu needed,
Table 1
Doubling times for strains with di¡erent plasmid-encoded EF-Tu variants and the e¡ect of inactivation of either or both tuf genes
Strain Chromosomal genotype Plasmid Doubling time (min)
MG1655 tufAþ, tufBþ pTRC99A 32
SR92 tufB: :kan pTRC99A 35
AZ32 tufA: :cat pTRC99A 44
SR143 tufA: :cat, tufB: :kan pTRCtufA 59
SR143 tufA: :cat, tufB: :kan pTRCtufACEX 72
SR143 tufA: :cat, tufB: :kan PTRCtufAZ2 109
SR143 tufA: :cat, tufB: :kan PTRCtufAZ3 109
SR143 tufA: :cat, tufB: :kan PTRCtufAZ4 147
SR143 tufA: :cat, tufB: :kan pTRCtufAZ5 100
Doubling time values were determined for strains with inactivated chromosomal tuf genes (SR143) with plasmids expressing wild-type EF-Tu
or CP-terminally tagged variants, as indicated.
Table 2
Kirromycin sensitivity test for plasmid-expressed EF-Tu and CP-ter-
minally tagged variants in strain UI232 (Ar, Bo)
Plasmid Amp Amp, IPTG Amp, Kir Amp, Kir, IPTG
pTRC99A + + + +
pTRCtufA + + + 3
pTRCtufACEX + + + 3
pTRCtufAZ2 + + + 3
pTRCtufAZ3 + + + 3
pTRCtufAZ4 + + + 3
pTRCtufAZ5 + + + 3
Growth of strain UI232 with di¡erent plasmids was tested on di¡er-
ent plates, as indicated. The change from kirromycin resistance to
sensitivity upon expression of the indicated EF-Tu variants includ-
ing the CP-terminally tagged constructs EF-TuCEX, EF-Tu-Z2, EF-
Tu-Z3, EF-Tu-Z4 or EF-Tu-Z5 is shown. Amp, ampicillin; Kir, kir-
romycin.
tufA(74.7 min) tufB(89.9 min)
tufA(74.7 min)
tufA(74.7 min)
Deletion of tufB
Introduction of plasmid
with tufA gene
kan
kan
kan
Plasmid with tufA gene
Plasmid with tufA gene
Deletion of tufA (P1 phage
Transduction)
cat
MG1655
SR92
SR92
SR143
Amp
Amp
Fig. 2. Inactivation of both chromosomal tuf genes. The tufB gene
was replaced with a kanamycin phosphotransferase cassette (kan) by
pKNG101-mediated chromosomal gene replacement, resulting in the
strain SR92(tufB : :kan). Next, in the presence of plasmids expressing
EF-Tu (pTRCtufA and pTRCtufACEX), the chromosomal tufA
gene was replaced with a chloramphenicol acetyltransferase cassette
(cat) by P1 phage transduction using a lysate originating from
AZ32 (tufA : :cat). The resulting strain was SR143 (tufA : :cat ;tufB : :
kan) with either plasmid pTRCtufA or pTRCtufACEX.
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the presence of IPTG is necessary for growth. The double
deletion strain is IPTG dependent, and the doubling time
values showed no signi¢cant di¡erence when IPTG was used
at 0.1 mM or 1.0 mM concentrations in the case of constructs
pTRCtufA and pTRCtufACEX. The higher IPTG concentra-
tion gave signi¢cantly faster growth in case of the CP-termi-
nally tagged constructs pTRCtufAZ2 and pTRCtufAZ3 (data
not shown). This indicates that even though the fused protein
is functional, the CP-terminal extensions decrease the e⁄ciency
of the EF-Tu cycle.
3.3. The plasmid replacement system
In the strain SR143, in which both tuf genes are inactivated,
plasmids encoding di¡erent EF-Tu variants could be ex-
changed by using plasmid incompatibility. To do this,
SR143 harboring the plasmid pTRCtufACEX was trans-
formed with the plasmid pTRCtufACEX-Tc and plated on
tetracycline/IPTG plates. Tetracycline-resistant transformants
were screened for ampicillin sensitivity. The resulting
AmpSTetR colonies harboring only the latter plasmid were
tested in further steps for kanamycin resistance, chloramphen-
icol resistance and IPTG dependence to con¢rm the chromo-
somal genotype and dependence on the plasmid-encoded tuf
gene. In this way, clones were isolated that harbor the plasmid
pTRCtufACEX-Tc instead of its ampicillin-resistant version
pTRCtufACEX, maintaining the chromosomal background
as in SR143.
The duration of the phenotypic expression step in these
plasmid replacement steps had to be 3^4 h long. The necessary
length of the phenotypic expression step can be correlated
with the three- to four-fold longer doubling time of these
strains (see also Section 2). Finally, cells were transformed
with the plasmid set encoding the engineered EF-Tu variants
pTRCtufAZ2, pTRCtufAZ3, pTRCtufAZ4 or pTRCtufAZ5.
The transformants were selected on ampicillin/IPTG plates
and screened for tetracycline sensitivity; this identi¢es clones
that have lost the shuttle plasmid but harbor the newly intro-
duced plasmids encoding the CP-tagged EF-Tu fusion proteins
(Fig. 3). The AmpRTetS colonies were tested in further steps
for kanamycin resistance, chloramphenicol resistance and
IPTG dependence phenotype. The kirromycin sensitivity of
these constructs was con¢rmed, and the expression of the
corresponding modi¢ed EF-Tu proteins were checked by af-
¢nity puri¢cation and gel electrophoresis (not shown).
3.4. Growth e¡ects by tuf-gene inactivation
The doubling time values of the constructed strains [tufA : :
cat (74.7 min); tufB : :kan (89.9 min)] with plasmids encoding
EF-Tu or CP-tagged EF-Tu proteins were used to compare the
e¡ect on growth of the engineered EF-Tu variants and their
wild-type counterpart. MG1655 with plasmid pTRC99A was
used as wild-type control. SR92[tufB : :kan] with pTRC99A
and AZ32[tufA : :cat] with pTRC99A were also used as con-
trols to identify the e¡ect of either tufA or tufB inactivation.
Derivatives of SR143 [tufA : :cat ;tufB : :kan] with plasmids
pTRCtufA, pTRCtufACEX, pTRCtufAZ2, pTRCtufAZ3,
pTRCtufAZ4 or pTRCtufAZ5 were also analyzed. The dou-
bling time values obtained in this experiment (Table 1) suggest
that even though the strains are viable, the CP-terminal exten-
sions have a negative e¡ect on EF-Tu function. This negative
e¡ect is correlated with the size of the CP-terminal tag. How-
ever, in the case of the longest extension, cultures tend to
grow faster as a result of recombinational loss of Z domain
fusion tags, as observed analyzing a⁄nity-puri¢ed fusion pro-
teins and plasmids from these constructions (not shown).
3.5. Analysis of EF-Tu-Zn proteins
The presence and stability of the EF-Tu-Z fusion proteins
in di¡erent strains was investigated by purifying these proteins
on IgG-Sepharose a⁄nity columns. A high yield of protein
was eluted from columns with samples from strain UI232 with
pTRCtufAZn plasmids. As expected, no signi¢cant amount of
protein material was recovered from the a⁄nity column for
cat kan
Tet
tufA-CEX
cat kan
Tet
tufA-CEX
Amp
tufA-Zn
pTRCtufAZn
plasmids
Amp
tufA-Zn
Fig. 3. Plasmid replacement technique based on plasmid incompati-
bility. The indicated EF-Tu-expressing plasmids were exchanged in
strain SR143 (tufA : :cat ;tufB : :kan). As a result, plasmids expressing
CP-terminally tagged EF-Tu variants are the sole sources of EF-Tu.
1     2   3    4    5
97 kD
66 kD
Fig. 4. SDS^PAGE analysis of CP-terminally tagged EF-Tu proteins
puri¢ed on IgG a⁄nity columns. Lane 1: EF-Tu-Z2, lane 2: EF-
Tu-Z3, lane 3: EF-Tu-Z4, lane 4: EF-Tu-Z5, lane 5: molecular
weight marker; bands corresponding to 66 and 97 kDa are indi-
cated.
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the control strain (UI232/pTRC99A). Samples of the IgG-Se-
pharose-puri¢ed material were analyzed using SDS^PAGE.
As can be seen in Fig. 4, the mobility of the protein bands
suggests a molecular weight that corresponds to the expected
sizes of the fusion proteins 60.1, 66.7, 73.2 and 79.8 kDa for
EF-Tu-Z2, EF-Tu-Z3, EF-Tu-Z4 and EF-Tu-Z5, respectively
(Fig. 4).
The fusion proteins were also isolated from strain SR143
(tufA : :cat ; tufB : :kan) harboring the plasmids pTRCtufAZ2,
pTRCtufAZ3, pTRCtufAZ4 and pTRCtufAZ5. The EF-Tu-
Z2 and EF-Tu-Z3 protein bands were homogeneous on SDS
gels, indicating that these constitutions are stable. In the case
of the two longest extensions, -Z4 and -Z5, the proteins iso-
lated from strain SR143 were not homogeneous. The observed
shortening of the fusion tag appears to be the result of plas-
mid recombination, as evidenced by analysis of plasmid prep-
arations from this strain (not shown).
Total cell protein samples from wild-type E. coli MG1655,
from the derived double deletion strain SR123/pTRCtufA
harboring a plasmid expressing wild-type EF-Tu, and from
SR123/pTRCtufAZ2 expressing a CP-terminally tagged EF-
Tu with 11 kDa higher molecular weight, were analyzed on
SDS gels (Fig. 5). The Coomassie-stained protein gel revealed
that the characteristic EF-Tu band (43 kDa) that is present in
the wild-type E. coli total protein sample was replaced by a
very prominent band (43 kDa) in the case of the SR123/
pTRCtufA sample. This re£ects the over-expression of EF-
Tu from the plasmid. The cells that had both chromosomal
tuf genes deleted and expressed CP-terminally tagged EF-Tu
from pTRCtufAZ2 as sole EF-Tu source, lacked the charac-
teristic EF-Tu band in the 43 kDa molecular weight range.
Instead, they gave a strong band corresponding to an EF-Tu-
Z2 over-expressed fusion protein in the expected 60 kDa size
range (Fig. 5).
4. Discussion
The IgG binding Z domain consists of 54 amino acid res-
idues (excluding extra sequences) [14], resulting in fusion tags
of 149, 207, 265, and 323 amino acid residues in length (in-
cluding linker and additional CP-terminal sequences). The
¢nding that the analyzed fusion proteins can support the com-
plex functional repertoire of EF-Tu in growing cells indicates
that the CP-terminus is probably not directly involved in the
cell in any essential binding interactions with other proteins or
complexes such as EF-Ts, tRNAs or the ribosome. These
engineered proteins therefore can be exploited in structural
analysis of the ribosome in its kirromycin-blocked state, serv-
ing as a physical reporter of the ribosome-bound EF-Tu.
Crystal structures of EF-Tu in complex with GTP and
tRNA [21] and the GTP^GDP exchange factor EF-Ts [22]
show that the CP-terminus is not part of the contact surface
of EF-Tu with these molecules. However, the NP-terminus is
probably involved in the ribosome-docking surface. Fitting
the components of the ternary complex into the cryo-electron
microscopy density-map of kirromycin-blocked ribosomes [23]
suggests that although the CP-terminal end of EF-Tu does not
take part in ribosomal interactions, this is not true for the
NP-terminal end. This observation is in line with our results:
NP-terminally tagged EF-Tu molecules proved to be defective
in function (not shown), suggesting the possible role of the
NP-terminal domain in the interactions mentioned above.
However, a three amino acid residues long extension in
the amino-terminus does not interfere with EF-Tu function
(Fig. 1, Table 2).
Due to the high level of EF-Tu needed in the cell, induction
of the plasmid-borne tuf gene is necessary for growth when
the sole EF-Tu source is a plasmid-encoded gene. Such IPTG
dependence is a helpful tool to analyze the plasmid and plas-
mid-encoded tuf gene dependence of the tufA- and tufB-de-
leted strains. The doubling time values showed no signi¢cant
di¡erence when IPTG was used at 0.1 mM or 1.0 mM con-
centrations in the case of constructs pTRCtufA and pTRCtufA-
CEX. However, the higher IPTG concentration gave signi¢-
cantly faster growth in case of the CP-terminally tagged
constructs pTRCtufAZ2 and pTRCtufAZ3 (data not shown).
This indicates that even though the fused protein is function-
al, the CP-terminal extensions decrease the e⁄ciency of the
EF-Tu cycle.
The CP-terminal extensions do have a negative e¡ect on EF-
Tu function, because the growth rate is decreased. This neg-
ative e¡ect on growth rate is correlated with the size of the
CP-terminal tag. However in the case of the longest extension,
the negative e¡ect is strong enough to provide a selection
pressure for the recombinational loss of Z domain fusion
tags. The duration of the phenotypic expression step in the
plasmid replacement steps had to be 3^4 h long. Based on our
experience, this might have been the reason why it appeared
to be di⁄cult to construct chromosomal deletions for both
tufA and tufB in the same strain. The necessary length of
this extended phenotypic expression step can be correlated
with the three- to four-fold longer doubling time of these
1         2        3        4         5
97
66
43
30
20.1
14.4
Fig. 5. SDS^PAGE analysis of EF-Tu in total protein samples. Pro-
teins originating from strain MG1655/pTRC99A (lane 1), SR143/
pTRCtufA induced with 0.1 mM IPTG (lane 2), SR143/pTRCtufA
induced with 1.0 mM IPTG (lane 3) and SR143/pTRCtufAZ2 in-
duced with 1.0 mM IPTG (lane 4). The molecular weight markers
are indicated in kDa (lane 5). The characteristic band corresponding
to EF-Tu appears in the 43 kDa molecular weight range in the sam-
ples analyzed in lanes 1^3. The prominent band with approximately
60 kDa molecular weight in lane 4 corresponds to EF-Tu-Z2, which
replaces the wild-type EF-Tu.
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strains (see also Section 2). The double deletion strain ex-
pressed undoubtedly more EF-Tu from the plasmid than
does the wild-type E. coli from the tufAþ and tufBþ genes
in the chromosome (Fig. 5).
The results described above indicate that in a tufB : :kan ;
tufA: :cat background the demonstrated plasmid replacement
technique using the pTRCtufaCEX-Tc as shuttle plasmid
makes it possible to exchange plasmid-encoded EF-Tu var-
iants. Thus, the genetic tools and strains used in this study
enable the analysis of EF-Tu mutants and to illustrate possi-
ble EF-Tu-A/EF-Tu-B functional di¡erences in vivo in the
strain SR143 lacking chromosomal tuf genes (vtufB : :kan ;
vtufA: :cat).
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